"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
Descriptor ID |
D012878
|
MeSH Number(s) |
C04.588.805 C17.800.882
|
Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 26 | 5 | 31 |
1995 | 32 | 4 | 36 |
1996 | 22 | 7 | 29 |
1997 | 33 | 4 | 37 |
1998 | 43 | 3 | 46 |
1999 | 29 | 5 | 34 |
2000 | 37 | 9 | 46 |
2001 | 40 | 3 | 43 |
2002 | 42 | 4 | 46 |
2003 | 66 | 12 | 78 |
2004 | 49 | 6 | 55 |
2005 | 61 | 12 | 73 |
2006 | 78 | 12 | 90 |
2007 | 69 | 6 | 75 |
2008 | 82 | 5 | 87 |
2009 | 68 | 7 | 75 |
2010 | 80 | 10 | 90 |
2011 | 102 | 9 | 111 |
2012 | 85 | 7 | 92 |
2013 | 82 | 10 | 92 |
2014 | 81 | 20 | 101 |
2015 | 82 | 10 | 92 |
2016 | 79 | 11 | 90 |
2017 | 103 | 7 | 110 |
2018 | 99 | 8 | 107 |
2019 | 74 | 6 | 80 |
2020 | 94 | 7 | 101 |
2021 | 83 | 6 | 89 |
2022 | 82 | 2 | 84 |
2023 | 65 | 2 | 67 |
2024 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. J Immunother Cancer. 2024 Mar 13; 12(3).
-
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma. J Immunother Cancer. 2024 03 11; 12(3).
-
Cutaneous melanoma in older patients. BMC Geriatr. 2024 Mar 06; 24(1):232.
-
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 03; 22(2):117-135.
-
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells. 2024 Feb 27; 13(5).
-
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe. JAMA Netw Open. 2024 Feb 05; 7(2):e2356479.
-
Association of autoimmune hepatitis with melanoma and nonmelanoma skin cancer: a case-control study using the All of Us Research Program. Clin Exp Dermatol. 2024 Jan 25; 49(2):180-181.
-
Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era. ESMO Open. 2024 Feb; 9(2):102193.
-
Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019. Front Public Health. 2023; 11:1267534.
-
Widespread Verrucous Plaques: Challenge. Am J Dermatopathol. 2024 Jan 01; 46(1):e7-e8.